Any patient can access Signos’ system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from Dexcom.
Related Posts
The Dow needs Nvidia to give chipmakers representation in index after Intel’s plunge
Intel has fallen so far so fast that the chipmaker’s stock price is no longer having an impact on the Dow Jones Industrial Average.
Bernstein says this tech stock is its best idea for 2025, could be added to the S&P 500
Square is one of Bernstein’s favorite names next year.
FBI raids home of John Bolton, former Trump national security advisor
FBI Director Kash Patel tweeted “NO ONE is above the law… @FBI agents on mission” as agents searched the home of John Bolton in Bethesda, […]